EUVIMEDEUVIMED entdecken
ValidierungsstudieLeitlinie

Guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services: MedinAI development, validation and statement

Wallace Entringer Bottacin, Thais Teles de Souza, Walleri Christini Torelli Reis, Ana Carolina Melchiors

International Journal of Clinical Pharmacy · 2025-08 · 47 (4) · 945-956

DOI: 10.1007/s11096-025-01905-3 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift International Journal of Clinical Pharmacy, online erschienen am 09.04.2025. Verfasst von Wallace Entringer Bottacin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pharmaceutical Services and Policies, Federal University of Paraná, Avenida Prefeito Lothário Meissner, 632 - Jardim Botânico…. Hauptthemen laut MEDLINE: Artificial Intelligence, Pharmaceutical Services, Drug Therapy, Research Design. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: PROPESQ/PRPG/UFPB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Artificial intelligence (AI) applications in medicines, pharmacotherapy, and pharmaceutical services are expanding, yet the lack of standardized reporting guidelines for scientific studies hinders transparency, comparability, and reproducibility in evidence-based healthcare decision-making. AIM: To develop and validate comprehensive reporting guidelines for AI studies in these fields through expert consensus. METHOD: Following the Guidance for Developers of Health Research Reporting Guidelines (Moher in PLoS Med, https://doi.org/10.1371/journal.pmed.1000217 , 2010), this study was conducted between May and October 2024 in two phases. Phase 1 involved drafting the initial guidelines through literature reviews and structured expert discussions by an internal committee. Phase 2 employed the Delphi method for validation and refinement. Twenty-six experts from nine countries, representing clinical pharmacy, pharmaceutical services, computer science, and AI, participated in the first round, with 21 completing the second round. Items were included if they received a median ≥ 7 on a 9-point evaluation scale, with ≥ 75% agreement defining publication consensus. RESULTS: The final MedinAI guidelines comprise 14 items and 78 sub-items across four domains: core aspects, ethical considerations in medication and pharmacotherapy, medicines as products, and services related to medicines and pharmacotherapy. All items achieved consensus (median = 8, with 95.2% agreement on publication readiness). MedinAI's items adapt to different AI development stages, and its structure operates in parallel with EQUATOR Network reporting guidelines for most study designs (CONSORT, STROBE, PRISMA, SPIRIT, etc.), ensuring versatility. CONCLUSION: MedinAI provides validated reporting guidelines for AI studies in medicines, pharmacotherapy and pharmaceutical services, promoting transparency, comparability, reproducibility, responsible and ethical AI development for these fields.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligencePharmaceutical ServicesDrug TherapyResearch DesignGuidelines as TopicHumansDelphi TechniqueReproducibility of ResultsConsensus

Stichwörter der Autor:innen

Artificial intelligenceDigital healthDrug therapyPharmaceutical servicesPublishing

Autor:innen und Institutionen

  • Postgraduate Program in Pharmaceutical Services and Policies, Federal University of Paraná, Avenida Prefeito Lothário Meissner, 632 - Jardim Botânico, Curitiba, PR, CEP 80210-170, Brazil. wallace.bottacin@gmail.com.
  • Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa, PB, Brazil.
  • Postgraduate Program in Health Decision Modeling, Federal University of Paraíba, João Pessoa, PB, Brazil.
  • Postgraduate Program in Pharmaceutical Services and Policies, Federal University of Paraná, Avenida Prefeito Lothário Meissner, 632 - Jardim Botânico, Curitiba, PR, CEP 80210-170, Brazil.

Förderung

  • PROPESQ/PRPG/UFPB

Zitieren

APA

Bottacin, W. E., de Souza, T. T., Reis, W. C. T., & Melchiors, A. C. (2025). Guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services: MedinAI development, validation and statement. International Journal of Clinical Pharmacy, 47(4), 945-956. https://doi.org/10.1007/s11096-025-01905-3

Vancouver

Bottacin WE, de Souza TT, Reis WCT, Melchiors AC. Guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services: MedinAI development, validation and statement. International Journal of Clinical Pharmacy. 2025;47(4):945-956. doi:10.1007/s11096-025-01905-3

BibTeX
@article{Bottacin2025,
  author = {Bottacin, Wallace Entringer and de Souza, Thais Teles and Reis, Walleri Christini Torelli and Melchiors, Ana Carolina},
  title = {Guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services: MedinAI development, validation and statement},
  journal = {International Journal of Clinical Pharmacy},
  year = {2025},
  volume = {47},
  number = {4},
  pages = {945--956},
  doi = {10.1007/s11096-025-01905-3}
}
Kostenlos starten →